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ABSTRACT 
 
Mass spectrometry-based shotgun proteomics has become one of the essential techniques for 
comprehensive studies of living systems. Due to the inherent complexity of proteomes and 
the data, bioinformatics plays a critical role to translate mass spectra into biological 
information and knowledge. Adapting to the increased availability of high-resolution mass 
analyzers, computational strategies for processing shotgun proteomics data should have 
some adjustments to utilize the advantages of modern instruments. This thesis presents five 
constituent papers to illustrate the methodological advancements for analyzing shotgun 
proteomics data that are generated from high-resolution mass spectrometry. Paper-I describes 
the DeMix workflow for protein identification, in which we broke down an old paradigm of 
tandem mass spectrometry by converting the unwanted co-fragmentation events into an 
advantage of natural multiplexing. DeMix simplifies the data processing procedure and 
significantly improves protein identification outcomes. Paper-III describes a label-free 
extension of the DeMix workflow, termed DeMix-Q, which makes use of the quantitative 
features of extracted ion chromatograms (XICs) for reliably propagating peptide 
identifications across LC-MS/MS experiments. DeMix-Q improves the reproducibility of 
peptide quantification by addressing the missing value problem that is caused by the data-
dependent acquisition of MS/MS. Based on the results, the concept of quantification-centered 
proteomics has been proposed. In the practice of quantification-centered proteomics, a flexible 
proteome summarizing approach termed Diffacto is described in Paper-V, which utilizes the 
information about covariation of peptides’ abundances to improve the relative quantification 
of proteins. Diffacto offers automatic quality control to remove inconsistent and unreliable 
quantitative data on peptides. The combination of a weighted summarizing method and an 
efficient FDR estimation provides significant enhancement of data utility for large-scale 
comparative proteomics. In Paper-II, an improved pI estimation method has been introduced 
to the novel device for sample fractionation based on isoelectric focusing technique. In Paper-
IV and V, the applications of peptide de novo sequencing have been demonstrated for 
analyzing complex proteomes in the absence of reference databases.  
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ABBREVIATIONS 
 
AA amino acid residue 
AMT accurate-mass-and-time 
AVONA  analysis of variance 
BLAST Basic Local Alignment Search Tool 
BSA bovine serum albumin 
CDR complementary determining region  
CID collision-induced dissociation 
cIEF  capillary isoelectric focusing 
CPTAC  Clinical Proteomic Tumor Analysis Consortium 
CV  coefficient of variation 
Da dalton, the unified atomic mass unit 
DDA data-dependent acquisition 
DIA data-independent acquisition 
ECD electron-capture dissociation 
ESI electrospray ionization 
ETD electron transfer dissociation 
FARMS  Factor Analysis for Robust Microarray Summarization 
FDR false discovery rate 
FQR false quantification rate 
FT Fourier transform 
FWHM full width at half maximum 
HCD higher-energy collisional dissociation 
HiRIEF high-resolution isoelectric focusing 
iPRG the ABRF Proteome Informatics Research Group 
iTRAQ isobaric tags for relative and absolute quantitation 
LC liquid chromatography 
LFQ label-free quantification 
m/z mass-to-charge ratio 
MC Monte Carlo 
MJ-cIEF  multijunction capillary isoelectric focusing 
MPIB  Max Planck Institute of Biochemistry 
MS mass spectrometry 
MS1 survey spectrum, the first stage of tandem mass spectrometry 
MS/MS tandem mass spectrometry 
PCR polymerase chain reaction 
pI isoelectric point 
PIP peptide identity propagation  
PMF peptide mass fingerprint 
ppm part per million 
PQPQ protein quantification by peptide quality control 
PSM peptide-spectrum match 
PTM post-translational modification 
S/N signal-to-noise ratio 
SpC spectral counting 
TMT  Tandem Mass Tag 
XIC extracted ion chromatogram 
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CHAPTER ONE: BACKGROUND 
 
 
 
 
 
 
Figure 1.1 | The central dogma of molecular biology.  
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1.1 Introduction 
 
 
Comprehensively understanding molecular and cellular functions is the key to systems 
biology (Kitano, 2002). Moving towards the ultimate goal of systems biology, revolutionary 
advancements in technology, such as the massive parallel sequencing and high-resolution 
mass spectrometry, have changed almost every aspect of biomedical research. In light of the 
central dogma of molecular biology (Crick, 1970), we started to bravely explore the vast 
territory of systems biology, from DNA through RNA to proteins and beyond.  
Proteomics is the system-scale study of proteins– the functional entities involved in 
almost all the biochemical processes– that is tightly related to systems biology (Weston and 
Hood, 2004). Compared to genomics and transcriptomics, respectively the studies of DNA 
and mRNA, proteomics did not benefit much from the massive sequencing technology. The 
reason is obvious, proteins (chains of amino acids) are fundamentally different from DNA 
and RNA (chains of nucleotides). Unlike in the processes of transcription (DNA to mRNA) 
and reverse-transcription (mRNA back to DNA), the information-flow is “irreversibly” 
encoded by nucleotide triplets (codons) in the process of translation (mRNA to protein). The 
combination of four nucleobases– A, C, G, and U (or T for DNA)– gives as many as 64 possible 
triplets, which causes the degeneracy of genetic code that exhibits redundancy for encoding 
the 20 amino acids. Besides, there is no evidence so far indicating an equivalent of the 
polymerase chain reaction (PCR) for reproducing proteins after the synthesis.  
Many believe that the protein abundances can be determined, to some extent, by the 
expression level of mRNAs (Gygi et al., 1999, Liu et al., 2016). This claim could be supported 
by an apparent correlation between the profiles of transcriptome and the proteome, if given a 
steady cellular state and the factors reflecting protein translation and degradation (Wilhelm 
et al., 2014, Liu et al., 2016). However, proteomes are the snapshots of living systems. Direct 
study of the performers of biological functions should give a higher accuracy of elucidating 
cellular mechanisms, compared to a study via the correlating entities (Wang et al., 2017). A 
complex system, e.g., a mammalian cell, often requires many copies of proteins to maintain 
the biological functions. Fortunately, to proteins in the scope of a cell, the relative scale of 
“many” is several magnitudes larger than that to the genes and transcripts. According to 
previous knowledge (Schwanhausser et al., 2011), the median protein abundance in a 
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mammalian cell is 50,000 copies, in contrast to the abundances of mRNAs (median 17 copies) 
and genes (one or two copies). Therefore, when the protein samples are collected, the most 
difficult job of amplifying the analytes has already been done. However, the analytical 
challenge is to capture a clear snapshot of the proteome. 
 
Mass spectrometry-based proteomics 
 
Lacking the equivalent of PCR, the technique of “sequencing by synthesis” is not feasible for 
analyzing proteins, and the traditional protein sequencing method– Edman degradation– could 
be extremely slow and costly for a system-wide analysis. Therefore, the contemporary 
strategy for proteomics is “divide and conquer”, which strives, by all means, to purify, isolate, 
break down, and subsequently measure the analytes.  
Multiple sources of information about the properties of proteins could be used to 
characterize the protein contents in the samples. Among the physiochemical properties of 
proteins, such as isoelectric point (pI), hydrophobicity, and antibody affinity, mass (with the 
symbol m) is perhaps the only intrinsic property that can be precisely measured. Importantly, 
regardless of the structure, the mass of a protein molecule can be determined by summing up 
the masses of all the elements of all its chemical components– amino acids, terminal groups, 
and modifications.  
Mass spectrometry (MS) is the analytic technique for measuring the masses (m), or 
more precisely speaking, the mass-to-charge ratios of the charged particles (Thomson, 1913). 
The principle of MS can be described by the Lorentz force law and the Newton’s second law 
of motion: 
𝑭 = 𝑞(𝑬 + 𝒗 × 𝑩) 
𝑭 = m ∙ 𝐚 
Equating the two expressions gives: 
(
𝑚
𝑞
) ∙ 𝐚 =  𝑬 + 𝒗 × 𝑩 
 
This equation describes the dynamics of charged particles in an electromagnetic field in 
a vacuum (𝑬: electric field, 𝒗 × 𝑩: vector cross product of the velocity and the magnetic field), 
where the change of velocity (𝐚) determines the mass-to-charge ratio (m/q) of the charged 
particle.  
ZHANG BO Ph.D. Thesis  
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The standard unit of the physical quantity of m/q is kilograms per coulomb (kg/C). To 
simplify the interpretation of data in mass spectra, the common notation for the mass-to-
charge ratio is m/z. In this notation, mass (m) is related to the unified atomic mass unit, dalton 
(Da), which is defined as one twelfth of the mass of a neutral carbon-12 (~1.6605402 × 10-27 kg); 
and the charge (z) is related to the elementary charge (e), which is the electric charge of a 
proton (~1.60217662×10−19 C). By this definition, the atomic unit of m/z is dimensionless, which 
is the ratio between the mass number and the charge number.  
Although proteomics relies on the different technology than genomics and 
transcriptomics, the field is not without revolutionary advancements. (Aebersold and Mann, 
2003, Aebersold and Mann, 2016). In fact, a comparably fast development of high-resolution 
mass spectrometers, with the increased accessibility, has already transformed proteomics. For 
instance, the Orbitrap mass analyzer (Makarov, 2000) has enabled high-resolution Fourier 
transform MS on a benchtop, which has been well adopted as a powerful technique in various 
protein-related biomedical research (Michalski et al., 2011b, Zubarev and Makarov, 2013). 
Thanks to the Orbitrap, deep profiling of complex proteomes became not only feasible 
(Thakur et al., 2011, Nagaraj et al., 2012) but also time-efficient (Richards et al., 2015), As a 
result, the comprehensive maps of the human proteome were eventually drafted (Kim et al., 
2014, Wilhelm et al., 2014), more than a decade after the availability of the human genome 
sequence (Lander et al., 2001, Venter et al., 2001).  
 
 
Separation prior to MS 
 
Complementary techniques are almost always applied in conjunction with MS, to provide 
extra dimensions for physical separation of proteins. Electrophoresis and liquid 
chromatography (LC) are the most commonly applied techniques.  
Electrophoresis separates proteins by moving the charged molecules in an electric field 
through a matrix or solution. The electrophoretic mobility depends on the net charge and the 
molecular weight of the analyte. Because proteins are zwitterionic molecules that may carry 
both positive and negative charges, each protein has an isoelectric point (pI). Therefore, 
isoelectric focusing (IEF), as one type of electrophoresis, provides a pH gradient to variate the 
net charges of analytes. When the pH of surrounding environment equals the pI of a particular 
protein molecule, the net charge of the zwitterionic molecule becomes zero (neutral), and 
consequently, the protein becomes stationary (focused) in the electric field.  
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LC, or more specifically, the reversed-phase LC separates molecules based on their 
hydrophobic characters, by dissolving and eluting samples from a non-polar stationary phase 
using a polar mobile phase that has a concentration gradient that changes the molecules’ 
affinities to the stationary phase. A high-performance LC uses a pump to force the sample 
solved in the mobile phase through the stationary phase. The instrumental setting of reversed-
phase (ultra)high-performance liquid chromatography coupled with mass spectrometry, 
(U)HPLC-MS for short, has become the most common technology used for in-depth 
proteomic analysis.  
Tandem layouts and combinations of these techniques can provide a multidimensional 
separation for approaching the rather comprehensive analysis of complex proteomes (Zhang 
et al., 2010). For example, the MudPIT approach (Link et al., 1999) combines two types of LC 
(ion-exchange and reversed-phase, IEX/RP-LC) and then connects to MS. For the first time, it 
provided a “comprehensive” analysis of over 100 proteins in a single experiment. With 
modern instruments, compared to its earlier implementations, such a two-dimensional LC-
MS system has become a hundred times more powerful that enabled profiling of over 10,000 
proteins (Geiger et al., 2012). More recently, the HiRIEF approach, which links the state-of-
the-art IEF, LC, and MS technologies, has demonstrated the deep proteome profiling of 
mammalian cells by quantitatively analyzing over 13,000 human proteins in a single 
experiment (Branca et al., 2014).  
 
Tandem mass spectrometry 
 
Although the mass of a protein could be precisely measured by MS, it is far from a unique 
identity of the protein and is not sufficient to infer the corresponding sequence of the protein. 
In a protein sequence, the number of possible combinations of 20 amino acids is enormous, 
which could form as many as 20n different sequences depending on the length (n). 
Consequently, based on a single value of m/z, it is rather difficult to deduce the elementary 
composition of large proteins and is almost impossible to know the order of the amino acids. 
However, the problem can also be solved in the manner of “divide and conquer” by breaking 
down the ion of the analyte to preferably two pieces and subsequently measuring the m/z of 
its fragments.  
The instrumental setting for this method is called tandem mass spectrometry (MS/MS 
or MSn) (McLafferty, 1981). MS/MS generates hierarchical mass information on the precursor-
fragments relations. MS/MS has four basic steps: isolation, activation, fragmentation, and 
ZHANG BO Ph.D. Thesis  
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detection. The first mass analyzer (e.g., a quadrupole) isolates the target precursors from other 
ions that have different m/z. After the isolation, precursor ions are stored in a chamber (e.g., 
an ion trap) where certain energy will be given to activate the precursors. Activation will 
eventually break down the amino acid backbones. For fragmenting the peptide ions, the most 
commonly applied method of activation is collision with neutral gas molecules (CID/HCD) 
(Mcluckey, 1992, Wells and McLuckey, 2005); and a less common method is transferring 
electrons to the positively charged molecules (ECD/ETD) (Zubarev et al., 1998, Syka et al., 
2004). Breakages on the amino acid chains will generate fragment ions (𝑚𝑓
+) and/or neutral 
particles (𝑚𝑛) that, in combination, compose the masses from the precursors (𝑚𝑝
+): 
𝑚𝑝
+ = 𝑚𝑓
+ +  𝑚𝑛 
Depending on the locations of backbone breakage, the fragment ions could form a 
ladder of masses that tells the composition and the order of amino acids, which is the sequence 
of the precursor. Detection of ions can be done in a high-resolution mass analyzer, (e.g., 
Orbitrap) for a high mass accuracy at the level of ppm. However, the mechanisms of 
fragmentation are not yet fully understood, and the backbone breakages are only empirically 
predictable (Degroeve and Martens, 2013). When the fragmentation does not follow the 
theoretical or empirical rules, it could be sometimes difficult to interpret the observed spectra 
(Palzs and Suhal, 2005, Zubarev et al., 2008). 
 
Shotgun proteomics 
 
Of the approximately 20,000 protein coding genes embedded in the human genome, the 
canonical human protein sequences have a median length of over 400 amino acids, and a 
median mass of over 45 kDa (UniProt, 2015). Ideally, proteins should be analyzed in their 
native forms that carry the full information about their sequences (Catherman et al., 2014). 
However, proteins often carry a wide variety of posttranslational modifications (PTMs). The 
combination of PTMs, isoforms, and mutations will result in an exponentially increased 
number of the forms of proteins (Cox and Mann, 2011), and many of them will likely have 
distinctive masses. Due to technical limitations, a “top-down” approach for direct 
measurement of all these “proteoforms” is rather difficult (Kelleher, 2004). Therefore, shotgun 
proteomics, an analog to the shotgun sequencing of genomes, has become the formidable 
technique in large-scale studies of complex proteomes, which is also known as the “bottom-
up” approach.  
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Figure 1.2 | Shotgun proteomics and LC-MS/MS. Purified proteins are digested into 
peptides using proteolytic enzymes (typically trypsin). Proteolytic peptides are 
separated by liquid chromatography (LC) according to hydrophobicity. Peptides eluted 
from LC are ionized (protonated) and injected into a mass spectrometer. The m/z values 
of peptide precursor ions are recorded in the survey MS spectra. After isolation, 
activation, and fragmentation, the m/z values of fragment ions are recorded in MS/MS 
spectra. The nomenclature for labeling the fragment ions was suggested by (Roepstorff 
and Fohlman, 1984) and modified by (Biemann, 1988). Collisional dissociation (CID and 
HCD) mainly produces b/y species of fragment ions.  
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Shotgun proteomics involves proteolytic digestion to cleave the intact proteins into 
proteolytic peptides. The digestion makes the analytes less heterogeneous and more friendly 
to MS. Trypsin exclusively cleaves the peptide bonds at the C-termini to lysine (Lys/K) or 
arginine (Arg/R) residue (Olsen et al., 2004), which is the protease of choice for a proteome-
scale digestion. Each of these two amino acids has an approximately 5% occupancy in human 
proteins. By tryptic digestion, the resultant proteolytic peptides have an average length 
around ten amino acids. Compared to that of intact proteins, the relative size of tryptic 
peptides is more amenable to MS.  
In addition, a full-tryptic digestion will yield peptides (most of which) containing only 
one lysine or arginine residue located at the C-termini of the sequences. According to the 
theoretical “mobile proton” model of fragmentation, protonated tryptic peptides are friendly 
to the collisional fragmentation (CID and HCD), because they are less likely to “sequester” the 
attached protons by the basic side chains (Palzs and Suhal, 2005, Swaney et al., 2010). 
 
Data acquisition 
 
Proteolytic digestion generates tens of peptides per protein, which inevitably causes new 
challenges for an MS-based analysis. First of all, MS is currently not fast enough to analyze all 
peptides in a reasonable amount of time. For instance, human cells may typically express 
about 10,000 genes and translate them into proteins. As the median length of human proteins 
is about 400 AA, one could expect to have on average 40 proteolytic peptides per protein, 
assuming a full digestion using trypsin. In this regard, even without considering sequence 
variations and PTMs, one would have at least 400,000 peptides to analyze in a single 
experiment. Given three hours for a single LC-MS/MS experiment, one needs to have an at 
least 40 Hz identification rate to get a full coverage of the expressed proteome. Currently, an 
Orbitrap mass analyzer has a maximum 18 Hz of acquiring high-resolution (15,000 FWHM) 
spectra; which empirically offers ca. 10 Hz identification rate in best scenarios with 50 to 60% 
success rate of MS/MS identification.  
Secondly, the dynamic range of proteins in mammalian cells spans over seven orders of 
magnitude (Schwanhausser et al., 2011), but a modern MS could barely reach five orders of 
magnitude, leaving a “dark corner” of the proteome consisting of mostly the least abundant 
proteins (Zubarev, 2013). The instrumental requirement for a comprehensive proteome-wide 
analysis is considerably high, which could be analogous to using one scale to measure the 
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weights of both a mosquito (~5 mg) and a human adult (~6o kg); or using one ruler to measure 
both the diameter of a human hair (~80 µm) and the height of the Eiffel Tower (300 m). 
In general, proteins with higher abundances give peptide ions that generate stronger 
signals and are easier to analyze. Thus, a strategy called data-dependent acquisition (DDA) 
for MS/MS is commonly applied in shotgun proteomics experiments. By the DDA approach, 
in every cycle of MS analysis, the most abundant precursor ions will be sequentially isolated 
for MS/MS. However, the DDA approach has a critical drawback– it is not entirely 
reproducible. That is to say, repeating the experiment with the same sample and the same 
instrument settings, one would obtain a somewhat different set of peptides derived from the 
MS/MS spectra (Tabb et al. 2010). The under-sampling problem leaves a serious concern 
about the reproducibility in proteomics experiments (Domon & Aebersold 2010). In order to 
avoid the stochasticity introduced by DDA, the targeted data acquisition could be applied, 
which specifies when to acquire an MS/MS spectrum of a specific precursor ion. The latter 
approach relies on the prior knowledge and allows for a limited list of targets, which makes 
it poorly suitable for the proteome-wide discovery. Alternatively, the data-independent 
acquisition (DIA) has been proposed to sequentially acquire MS/MS spectra for a wider m/z 
range (compared to DDA and targeted approaches) of precursors in an unbiased manner 
(Gillet et al., 2012, Egertson et al., 2013). 
The choice of data acquisition method depends on the purpose of a study, and the 
balance between the discovery and validation, as well as between sensitivity and 
reproducibility (Leitner and Aebersold, 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
ZHANG BO Ph.D. Thesis  
- 14 - 
 
 
 
 
 
 
 
Figure 1.3 | Data-dependent vs. data-independent acquisition of MS/MS spectra. 
DDA targets the most intensive precursors that are observed in the survey MS. Narrow 
isolation windows (usually, m/z < 4.0) are often used to separate targeted precursor ions 
for MS/MS. To prevent repetitively analyzing the same targets within a short time, the 
mechanism of dynamic exclusion applied in DDA introduces a stochastic tendency in 
the MS/MS data. In contrast, DIA does not target specific precursors and does not 
necessarily require survey MS for acquiring precursor information. Wide isolation 
windows (typically, m/z > 20) are sequentially used for acquiring MS/MS spectra in an 
unbiased manner. Consequently, DIA-derived MS/MS spectra are often more complex 
and noisy than that of DDA, due to co-fragmentation of the mixture of precursor ions. 
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1.2 Bioinformatics 
 
 
MS-based shotgun proteomics could be categorized as a high-throughput, data-driven 
research field (Cox and Mann, 2007, Cox and Mann, 2011), generating huge amounts of data 
that require highly efficient software for downstream analysis. Proteomics, in this regard, is 
also an interdisciplinary field, in which, bioinformatics plays a critical role in making sense of 
the data, and ultimately transforming mass spectra into the knowledge related to biological 
systems.  
Compared to the rapid instrumental developments, the data analysis paradigms and 
computational methods for shotgun proteomics have not changed much since its early ages. 
Especially, the dramatically improved resolution and mass accuracy have not been fully 
utilized (Olsen et al., 2005, Zubarev and Mann, 2007). Apparently, developments in 
bioinformatics for proteomics are lagging behind other fast-growing ‘omics fields.  
Here, I will briefly introduce the common bioinformatics methods for proteomics, and 
address the current methodological limits in analyzing high-resolution and high-throughput 
data, which can be improved by the studies included in this thesis.  
 
Identification 
 
In shotgun proteomics, the analytes of an LC-MS/MS experiment are ionized proteolytic 
peptides. Unlike DNA sequencing, the typical readout from a mass spectrometer is not the 
processed information about the sequence itself, but the much less intuitive m/z values. Due 
to the inherent complexity, it could be one of the most diverse and challenging tasks in 
shotgun proteomics to associate a set of m/z values to the identity of a certain peptide 
(Marcotte, 2007).  
In order to know the mass (m) of a given peptide, one needs to determine its charge 
state (z). Fortunately, as proteins and peptides are carbon-based macromolecules, multiple 
isotopic peaks may be observed due to the natural abundances of stable isotopes of chemical 
elements, especially the relatively abundant (~1.1%) carbon-13. High-resolution MS (e.g., 
FWHM > 15,000) can well distinguish the m/z difference between peptide ions (m ≪ 100 kDa) 
ZHANG BO Ph.D. Thesis  
- 16 - 
 
with different compositions of stable isotopes, for example, between carbon-12 and carbon-13 
(∆m = 13C - 12C =1.003355 Da ≈ 1 Da). The charge state could be determined by the m/z 
difference between two isotopic peaks, 𝑧 = Δ𝑚 𝑧⁄
−1
. For example, a difference of Δ𝑚 𝑧⁄  = 0.5 
indicates a doubly charged precursor, while a Δ𝑚 𝑧⁄  = 
1
3⁄  difference means triply charged 
ions, and so forth.  
In addition, it is important to determine the monoisotopic mass, which is the mass of 
the analyte molecule where each of the chemical elements is from the most abundant isotopes, 
such as 1H, 12C, 14N, 16O, as well as 32S. Because the 1 Da mass difference between the stable 
isotopes of carbon is slightly different from (~ 6.3 mDa heavier than) that between the isotopes 
of nitrogen, the “fine structures” composed of peaks of various (heavier) isotopes are often 
convoluted into a broader peak, whose position is defined less accurately than that of the 
monoisotopic peak. Resolving isotopic fine structures requires ultrahigh resolution (e.g., 
FWHM 500,000 to 1,000,000) that is available exclusively through FTMS. Importantly, the 
monoisotopic mass is additive, while the most abundant isotopic mass is not.  
As mentioned before, the peptide mass alone might not be a unique identity of the 
sequence, but combining extra-dimensional information (RT or pI) with the mass may create 
peptide mass fingerprints (PMFs) that greatly improves the specificity (Smith et al., 2002, Pasa-
Tolic et al., 2004). More detailed and reliable information about the peptide sequence is stored 
in MS/MS spectra. SEQUEST (Eng et al., 1994) and Mascot (Perkins et al., 1999) are the two 
traditional tools that are widely used in proteomics for identification of peptides from MS/MS 
spectra. Both are in the category of MS/MS database search engine that matches the peptide 
fragment fingerprints (PFFs) to the theoretical fragments in silico generated from a database 
of protein sequences. The certainty of a peptide-spectral matching (PSM) is estimated from 
the probability of randomly matching the MS/MS spectra to the theoretical peaks (p-values), 
or the expected number of random matchings in the given database (E-values). However, both 
search engines were developed quite a while before the prevalence of high-resolution 
instruments. Since then, many new algorithms have been proposed to improve the accuracy 
and reliability of peptide identification (Käll et al., 2007, Cox et al., 2011b, Kim and Pevzner, 
2014). 
Instead of matching experimental peaks to the theoretical peaks in a database search, 
spectra that have been previously identified can also be used as a reference library for 
matching (Lam and Aebersold, 2011, Yen et al., 2011). This approach is often applied for 
analyzing DIA data (Schubert et al. 2015). Compared to database searching, this method offers 
higher specificity but is still limited by the empirical knowledge stored in the spectral library. 
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The drawback of using a protein database or a spectral library is the little tolerance to 
any sequence variation or posttranslational modification (PTM). PTMs and mutations will 
accordingly introduce mass shifts to the masses of peptide ions, as well as the related 
fragments. In fact, a large proportion of unidentified spectra might probably be peptides that 
carry sequence variants and PTMs (Savitski et al., 2006b), and the border between mutations 
and PTMs is blurry. For example, a methylated aspartic acid (Asp) is identical to a glutamic 
acid (Glu) from the m/z point of view. Wrong conclusions can be drawn from using an 
inappropriate database (Knudsen and Chalkley, 2011). Therefore, identification and 
localization of PTMs and mutations require either a modification to the theoretical masses or 
a searching strategy that tolerates mass errors (Mann and Wilm, 1994, Chick et al., 2015). 
 
 
Table 1 | Mass increments (∆m) of canonical amino acid residues.  
 
Amino acid Code Monoisotopic mass Amino acid Code Monoisotopic mass 
Glycine G 57.02146 
Glutamine 
Q 
(GA/AG) 
128.05858 
Alanine A 71.03711 
Serine S 87.03203 Lysine K 128.09496 
Proline P 97.05276 Glutamate E 129.04259 
Valine V 99.06841 Methionine M 131.04049 
Threonine T 101.04768 Histidine H 137.05891 
Cysteine C 103.00919 Phenylalanine F 147.06841 
Leucine/Isoleucine L/I 113.08406 Arginine R 156.10111 
Asparagine N (GG) 114.04293 Tyrosine Y 163.06333 
Aspartate D 115.02694 Tryptophan W 186.07931 
 
The mass is identical between leucine (L) and isoleucine (I).  
The mass of asparagine (N) equals the mass two glycine residues (GG), and the mass of glycine-alanine (GA) is 
indistinguishable from that of glutamine (Q).  
Glutamine (Q) is less than 36.4 mDa (0.03%) lighter than lysine (K).  
Carbamidomethylation is a deliberate PTM introduced to cysteine residues during sample preparation, which 
gives a mass shift of +57.02146 Da to the mass of cysteine.  
Oxidation is also a common PTM that introduces a +15.99491 Da mass shift.  
 
 
Nevertheless, it is possible to wholly or partially construct the peptide sequences 
directly from MS/MS spectra. Tools for peptide de novo sequencing (Taylor and Johnson, 1997, 
Frank et al., 2007, Ma and Johnson, 2012) have evolved from the early approach of sequence 
tags (Mann and Wilm, 1994).  The de novo approaches directly infer the sequence of a peptide 
from the mass increments (Table 1) in the ladder of fragment peaks, without any prior 
knowledge of the protein sequences. Peptide de novo sequencing requires almost full backbone 
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coverage from the fragments and works best with short and lower-charged peptides. 
However, amino acids having the same masses (Table 1) can hardly be distinguished, and the 
introduction of sequence variances and PTMs can make the sequencing process even more 
difficult and less accurate. In order to improve the accuracy of peptide de novo sequencing, 
high-resolution spectra with complementary fragmentation techniques (e.g., HCD+ETD) are 
highly recommended (Nielsen et al., 2005, Zubarev et al., 2008, Chi et al., 2013). In practice, 
this approach is mainly used when a reference protein database is not available, for example, 
sequencing of antibodies (Bandeira et al., 2008). 
 
 
Quantification 
 
The changes of protein abundances can reflect the systematic responses to perturbations. In 
various contexts, differentially expressed proteins could reveal the key components of 
biological pathways and interaction networks, thus could be used as biomarkers for disease 
diagnose, or potential therapeutic targets for treatments. Accordingly, many proteomics 
studies have a common design, which is quantitative profiling of the protein contents of in 
different systems (e.g., perturbed vs. unperturbed) followed by comparative analysis (Ong 
and Mann, 2005). 
Fortunately, modern mass spectrometers provide a decent quantitative accuracy and a 
relatively wide dynamic range that is suited for the proteome-wide analysis (Zubarev, 2013). 
Most of the time, protein quantification is done on a relative scale by comparing protein 
abundances between the samples. It is, however, possible to estimate the absolute protein 
abundance (e.g., copy number per cell) by comparing measured abundances to internal 
standards with know absolute concentrations (Gerber et al., 2003, Silva et al., 2006, Wiśniewski 
et al., 2014). 
Quantitative analyses have two main approaches: stable isotopic labeling and the 
alternative, label-free quantification (Bantscheff et al., 2007, Cappadona et al., 2012). The 
labeling techniques, such as iTRAQ (Ross et al., 2004), TMT (Thompson et al., 2003), and 
SILAC (Mann, 2006), provide the power of multiplexing to MS analysis (Rauniyar and Yates, 
2014). By isotopic labeling, as many as ten (or even more) samples can be quantified 
simultaneously in the same LC-MS/MS experiment (McAlister et al., 2012, Werner et al., 
2014). However, the increased multiplexing ability comes at a price. As mentioned before, it 
requires ultrahigh resolving power (> 70,000 FWHM at 200 m/z) to distinguish the densely-
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coded mass tags (Hebert et al., 2013, Rose et al., 2013, Merrill et al., 2014). By the labeling 
approach, the quantitative information is often obtained by comparing the intensities of the 
same ionic species, but with different isotopic compositions. Inevitably, the process of 
quantification is built on top of the identification results that attribute the peptides’ quantities 
to the source proteins; thus, errors in identification will cause imprecise quantification. 
 
 
 
 
 
 
Figure 1.4 | Quantification techniques for shotgun proteomics. Adapted from 
(Bantscheff et al., 2007, Bantscheff et al., 2012). Solid capsules represent samples labeled 
by stable isotopes (e.g., 13C and 15N), while empty capsules represent unlabeled samples. 
Metabolic labeling methods (e.g., SILAC) incorporate heavy isotopes into living 
systems. Chemical labeling introduces post-translational modifications to specific 
amino acid residues or terminal groups using reagents with stable isotopes. Popular 
chemical labeling techniques (e.g., TMT and iTRAQ) are usually applied after protein 
digestion. Spike-in approaches combine a quantitative standard (labeled) into each 
protein sample. For example, in super-SILAC, an isotope-labeled cell mixture can serve 
as the internal standard (Geiger et al., 2010). Isotope labeling (metabolic and chemical) 
enables multiplexing, i.e., quantifying more than one sample in each LC-MS/MS 
experiment. Label-free quantification measures each sample individually. 
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LFQ, on the other hand, is appealing for having less experimental steps and is not 
limited by the size of studies. However, it requires for each sample an individual LC-MS/MS 
experiment (Hein et al., 2012). The very basic method of LFQ is spectral counting (SpC), which 
relies on counting the number of identified MS/MS spectra to approximate the relative 
logarithm of the abundance of the proteins (Liu et al., 2004, Ishihama et al., 2005, Griffin et al., 
2010). However, SpC is often deemed as semi-quantitative and has poor performance for 
lower abundant proteins with few identified peptides (Tabb et al., 2015). The more accurate 
solution is based on extracted-ion chromatograms (XICs) that can be applied to both 
precursors and fragments depending on the data acquisition mode (DDA or DIA). By 
measuring the time-dependent eluting profile of the ions, one can generate a map of 
chromatographic features that contains the quantitative information about the peptides, even 
without being associated with the corresponding sequences.  
Larger variances might be introduced into data analysis while combining multiple 
experiments. Compared to the labeling approaches, LFQ has a greater challenge of controlling 
the run-to-run variances. Especially, as mentioned before, the identification of peptides can be 
more or less different from run to run, due to the stochastic tendency in DDA. If the 
quantification is performed on top of the identification result, many peptides will have 
missing abundances in some of the experiments. The problem with missing values could be 
seen as one of the biggest obstacles in LFQ. For this reason, many sophisticated algorithms 
have been proposed for LFQ to address the issue with significant variances (Clough et al., 
2012, Lyutvinskiy et al., 2013, Cox et al., 2014). Moreover, computational efficiency might also 
be concerned in a large-scale implementation (Khan et al., 2009). Comprehensive reviews of 
LFQ algorithms can be found in recent studies (Matzke et al., 2013, Sandin et al., 2014).  
 
 
Proteome-wide summarization 
 
Shotgun proteomics involves proteolytic digestion, which breaks proteins down to peptides. 
In this scenario, an extra but necessary procedure is to reconstruct proteins based on the 
identified peptides, which is called “protein inference”. Due to sequence homology, the links 
between some of the peptides and the original protein molecules might no longer be unique 
after the digestion. A practical approach to protein inference is to apply the principle of 
parsimony and assembles the entire set of identified peptides into the least possible number 
of distinguishable protein groups (Nesvizhskii et al., 2007, Ma et al., 2009). Alternatively, 
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proteins could also be inferred based on likelihoods (Serang and Noble, 2012) or quantitative 
patterns (Forshed et al., 2011, Lukasse and America, 2014). 
Compared to the already difficult problem of protein inference, quantitative estimation 
of protein concentrations is more complicated, as it is based on multiple measurements of 
individual peptides. A common assumption is that the peptides’ abundances are proportional 
to the concentration of the source proteins (Walther and Mann, 2010). Accordingly, summing 
up peptide abundances is the approach that is well adopted in shotgun proteomics 
(Schwanhausser et al., 2011, Wilhelm et al., 2014). The question is, do all the peptides from the 
same source protein response equally to the concentration change? The answer might likely 
to be negative because multiple factors are involved in the quantitative measurements of 
peptides, many of which can violate the assumption of proportionality. Such factors include 
efficiency of enzymatic cleavage, peptide ionization efficiency, charge distribution, mass 
range of the instrument, sequence variance and homology, and so forth (Bantscheff et al., 
2012). However, the biggest obstacle is still related to missing values, which are frequently 
encountered, especially in LFQ. By aligning the chromatographic features, identities of some 
peptide may be propagated across LC-MS runs even in the absence of an MS/MS evidence 
(Thakur et al., 2011, Bateman et al., 2013, Weisser et al., 2013). Other procedures including 
imputation are often needed for enabling proteome-wide summarization of protein 
abundances and their comparisons (Karpievitch et al., 2012). 
 
 
Integrative workflows 
 
The field of proteomics is diverse, not only in the technological choices but also the analytical 
methods. Practically, no “one-size-fits-all” strategy could be applied universally in proteomic 
studies (Mallick and Kuster, 2010). Consequently, data analysis workflows often need to be 
tailored for specific types of applications and instruments.  
Common procedures in shotgun proteomics processing include MS data format 
conversion, mass peak picking, spectral quality control, chromatographic feature detection, 
retention time alignment, mass calibration, MS/MS database search, FDR estimation, protein 
inference, protein quantification, spectral annotation, visualization, and so forth. Since many 
of these procedures could be standardized, many integrated workflows, such as the 
commercial ProteomeDiscoverer package and the freeware MaxQuant (Cox and Mann, 2008), 
have gained popularity for providing bundles of pre-optimized tools for efficient processing 
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of typical proteomic datasets. However, the source codes of these programs are unavailable 
to general users, which reduces the flexibility of data analysis. In contrast, the OpenMS 
Proteomics Pipeline (Kohlbacher et al., 2007) is an open-source platform that provides greater 
flexibility for building customized analytical pipelines, especially for analyzing non-typical 
datasets.  
Besides the main processes of protein identification and quantification, the pre-
processing and post-processing steps could also affect the analytical performance (Wenger et 
al., 2011). Important pre-processing steps include precursor mass calibration (Cox et al., 
2011a), deconvolution of charges and isotopes, spectral cleaning, as well as demultiplexing of 
chimeric MS/MS spectra (Egertson et al., 2013). One post-processing procedure, which has 
become standard in proteomic analysis, is estimating the FDR of identification based on the 
theory of target-decoy competition (Elias and Gygi, 2007). For a given scoring threshold, the 
proportion of spectra matching to decoy (reversed or shuffled) sequences can reflect the 
fraction of false discoveries in the identification list. Base on the theory, advanced algorithms 
(e.g., Percolator) can be applied to calculate the posterior-error-probabilities (PEPs), giving a 
more accurate approximation of the FDR (Käll et al., 2007, Käll et al., 2008). Different methods 
may have various scoring schemes for peptide-spectral matching. Thus, it is also important to 
generate a consensus result when peptide-spectral matches are divergent (Shteynberg et al., 
2013). A protein group having more than one unique peptides could be considered more 
reliable than the “one-hit wonders” (Ong and Mann, 2005, Huang et al., 2012). Sophisticated 
protein inference approaches are especially useful when the number of identifications is large 
and when the FDR estimation at the protein level is no longer accurate. However, FDR 
estimation at the protein level is always harder and less accurate than for the peptide-spectral 
matches (Nesvizhskii et al., 2003, Serang et al., 2010, Savitski et al., 2015). 
 
 
 
1.3 Comparative proteomics 
 
 
Currently, the most common design in proteomics studies is the comparative analysis of two 
or more sample groups. In this context, the relative quantification approach plays a significant 
role in investigating the similarities and discrepancies at the protein level between the distinct 
functional states of the living systems. Changes of proteins’ concentrations may indicate the 
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cellular responses to perturbations in a biological system. Covariation of the abundance 
changes may provide information about protein interaction and signal transduction 
pathways. Key nodes in the protein networks may serve as biomarkers or therapeutic targets 
for complex diseases. The challenge in comparative analysis is to discriminate signals from 
noises (Matzke et al., 2013). Therefore, advanced statistical methods and large sample sizes 
are often needed (Serang and Käll, 2015). For increasing sample size, highly multiplexed 
techniques, such as neutron-encoded labeling (McAlister et al., 2012, Hebert et al., 2013, 
Savitski et al., 2014), can be applied; LFQ, on the other hand, offers a simpler solution for 
further expanding proteomic studies to larger sample sizes, if only the issue with 
reproducibility could be well-addressed (Tabb et al., 2016).  
 
 
1.4 Aims 
 
 
The general aim of this thesis is to provide a set of advanced bioinformatics methods for 
extracting biologically relevant information from proteomics datasets. The main focus is on 
improving the data utility for high-resolution tandem mass spectrometry that could facilitate 
biomedical research.  
The specific aims in the constituent papers are:  
• to establish a computational workflow for efficient processing of high-resolution 
mass spectrometry data and improving peptides identification results (Paper-I), 
• to illustrate a novel method for predicting the isoelectric point of peptides and 
proteins based on a new cIEF device (Paper-II), 
• to establish a novel workflow for improving the reproducibility of XIC-based 
peptide quantification, and to introduce a quantification-centered analytical 
paradigm for enhancing data utility in proteomics (Paper-III), 
• to propose a novel analytical approach for studying human antibodies in blood as 
disease biomarkers (Paper-IV), 
• to describe an advanced algorithm for protein quantification, and to propose a 
flexible and reliable data analysis strategy for designing and conducting large-scale 
comparative proteomics studies (Paper-V). 
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CHAPTER TWO: PRESENT INVESTIGATIONS 
 
 
 
2.1 Methodological considerations 
 
 
LC-MS/MS 
 
Proteomics experiments performed for this thesis were carried out with high-performance 
reversed-phase LC systems made by Thermo Fisher Scientific: EASY-Spray C18 columns (50 
cm in Papers I and V, 15 cm in Papers II and IV), or in-house packed 10 cm C18 column (Paper-
IV). Positive mode electrospray ionization (ESI) was used for coupling LC to MS. Fourier-
transform mass spectrometry (FTMS) were performed with Orbitrap mass analyzers made by 
Thermo Fisher Scientific: Velos (Paper-II), Q-Exactive (Paper-I), Q-Exactive Plus (Papers IV 
and V) and Fusion (Paper-IV). In Paper-II, an additional dimension of sample separation was 
applied prior to LC-MS/MS, which used the cIEF technique that will be described later.  
The data-dependent acquisition (DDA) was applied. In Paper-I, four different isolation 
windows (±1.0, ±2.0, ±3.0, and ±4.0 m/z) were used for investigating the specificity of precursor 
selection and the effect of multiplexing. Basically, a wider isolation window gives less 
specificity to the precursor ions and generates complexed spectra due to co-fragmentation of 
precursors. Further widening the isolation windows will decrease the specificity of the 
precursor-fragments relations in MS/MS, and will yield noisy chimeric spectra that are 
similar to DIA-MS/MS. However, processing DIA-derived data requires a different strategy 
to deconvolute each of the MS/MS spectra and reconstruct the information on the precursor-
fragments relations (Egertson et al. 2013; Tsou et al. 2015).  
In addition, a segmented DDA strategy (Vincent et al., 2013) was applied in Paper V, by 
limiting the range of precursor m/z in low, mid and high three non-overlapping mass ranges 
for triggering DDA. Such strategy intentionally reduced data redundancy of MS/MS for 
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investigating the quantification quality after implementing peptide identity propagation (PIP) 
across LC-MS/MS runs.  
Higher-energy collisional-induced dissociation (HCD) was the default technique 
applied for fragmentation. Electron-transfer dissociation (ETD) was also implemented in 
Paper-IV, in order to generate complementary fragment ions in the HCD-ETD spectral pairs 
for reliable peptide de novo sequencing.  
 
MJ-cIEF device and pI 
 
In Paper-II, an additional dimension of sample separation was applied using the newly 
developed isoelectric focusing device: pI-Trap (multiple-junction capillary isoelectric focusing 
fractionator, MJ-cIEF). The pI is defined as the point of pH value at which a given peptide 
acquires a net charge of zero. The net charge of peptides could be calculated based on the 
equations derived from the Henderson–Hasselbalch equation, which was described in details 
in the reference of Protein Modification Screening Tool (ProMoST) (Halligan, 2009).  
The negative charge (𝐶−) is determined by the pH of the environment and the pKa value 
of each of the 𝑛 negative groups. 
𝐶− = ∑
−1
1 + 10𝑝𝐾𝑎(𝑖)−𝑝𝐻
𝑛
𝑖=1
 
 
Similarly, the positive charge (𝐶+) is determined by the pH of the environment and the 
pKa value of each of the 𝑚 positive groups. 
𝐶+ = ∑
1
1 + 10𝑝𝐻−𝑝𝐾𝑎(𝑖)
𝑚
𝑖=1
 
 
When setting the net charge (sum of the positive and negative charges) to zero: 
𝐶− + 𝐶+ = 0 
the corresponding pH (i.e., the estimated pI) could be determined by the pKa values of 
the chargeable groups in the chain of amino acids. The pKa values of chargeable groups were 
obtained from the website of ProMoST 1  (Halligan, 2009). 
                                                     
1 http://proteomics.mcw.edu/promost.html 
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Figure 2.1 | Calibration of pI gradient for the MJ-cIEF sample fractionator (pI-Trap). 
Peptides are injected into the cIEF device, focused in the capillary column based on their 
pI properties, and then collected in different fractions depending on the time of flowing 
through the column. Abundant peptides observed in multiple fractions are used as 
markers for connecting the fractional location of the capillary column to the theoretical 
pI values. Center locations of the marker peptides in the cIEF column are estimated by 
fitting skewed Gaussian curves to the relative peptide abundances observed in different 
fractions. Theoretical pI values are predicted by computationally approximating the 
optimal pH that yields the minimal net charge of the peptide molecules. (Colors indicate 
the pH or pI: blue basic, red: acidic).  
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Chargeable groups include side chains of acidic (negative) residuals: glutamic acid (E), 
aspartic acid (D), tyrosine (Y), and basic (positive) residuals histidine (H), lysine (K), and 
arginine (R). However, the Cysteine (C) side chain with the fixed modification 
(carbamidomethylation) was not considered as a chargeable group. Terminal groups (N-
terminus and C-terminus) are also chargeable but were considered individually for the 20 
terminal amino acids. A Python script has been developed for calculating the optimal pH 
value by approximating the minimum net charge for a given sequence of amino acids. 
The information on pI of the peptides was associated with the fractional location of the 
cIEF device. Peptides collected from more than three fractions were chosen as the self-
calibrating markers. Skewed Gaussian curves were fitted to the observed peptide abundances, 
producing the estimated center locations of the marker peptides. Theoretical pI values and the 
center locations of the marker peptides were connected by five-degree polynomial curve-
fitting, which transformed the fractionator to a non-linear pI gradient (Figure 2.1).  
 
 
External datasets 
 
Data generated from different laboratories are especially useful for testing the compatibility 
of the data processing approaches. In Paper-I, the reference dataset produced by researchers 
from University of Texas Southwestern (Guo et al., 2014) was used to validate that the new 
peptide identifications are not artifacts. Paper-III and V used the data of the ABRF-iPRG2015 
study (Choi et al., 2017), to assess the reproducibility of peptide quantification. The iPRG 
study contains 12 single-shot LC-MS/MS (Orbitrap) experiments that measured four samples 
with a common background proteome and six marker proteins spiked in by different 
concentrations. In Paper-V, to demonstrate the consistency of the protein quantification 
results, two datasets were obtained from supplementary materials of two clinical studies of 
breast cancer: 1) The CPTAC breast cancer dataset (Mertins et al., 2016) contains 77 breast 
cancer samples (quality control passed) analyzed by iTRAQ experiments; and 2) The MPIB 
dataset acquired from the study conducted at the Max Planck Institute of Biochemistry, 
Germany (Tyanova et al. 2016), which contains 40 breast cancer samples compared to a spike-
in standard (super-SILAC) of isotopic-labeled mixture of breast cancer cell cultures.  
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Identification 
 
Search engines. Mascot (Perkins et al., 1999) was used in Paper-I to benchmark the 
improvements from other advanced methods. In Paper-I and Paper-III, the “universal” search 
engine MS-GF+ (Granholm et al., 2014, Kim and Pevzner, 2014) was implemented, to achieve 
the deepest proteome coverage. In Papers-I, II, III, and V, the Andromeda search engine (Cox 
et al., 2011b) was used, which is integrated into the popular MaxQuant package (Cox and 
Mann, 2008, Michalski et al., 2011a, Tyanova et al., 2016). With high-resolution MS/MS and 
the target-decoy strategy (Elias and Gygi, 2007), matching MS/MS spectra to the protein 
database can be simplified to counting of observed fragment ions with little tolerance to mass 
errors (< 20 ppm). Applying the fragment counting strategy, the Morpheus search engine 
(Wenger and Coon, 2013) was used in Papers I, IV, and Paper-V. On top of Morpheus-derived 
PSM results, an advanced scoring strategy was proposed in Paper-I with improved usage of 
the mass accuracy (Zubarev and Mann, 2007) and the information on complementary 
fragment pairs (i.e., b/y ion-pairs).  
Precursor information. Reliable peptide identification based on MS/MS requires 
accurate m/z of the precursor ions measured in the survey spectrum (MS1). In Papers-I, II, III, 
and V, the precursor mass information was firstly calibrated by identifications from the first-
pass database search. Systematic mass deviations were automatically corrected by offsetting 
the average mass error for each of the precursors, then search the MS/MS spectra again with 
the calibrated precursor information. The concept used in this approach is called “software 
lock-mass” (Cox et al., 2011a).  
DDA-derived MS/MS usually records one precursor m/z per spectrum, which 
implicates only one peptide identification from the spectrum. However, in a rapid analysis of 
a complex proteomic sample (e.g., human cells), the distribution of precursor ions in a given 
mass range is considerably dense (Michalski et al., 2011a). Consequently, only in rare cases, 
the precursor ions collected within the isolation window could be pure. In this regard, most 
of MS/MS spectra are chimeric, “naturally” containing extra pieces of information about co-
fragmenting precursors. Associating these additional precursors with the MS/MS spectra, a 
set of MS/MS “clones” were generated. Such a strategy for naturally multiplexing of MS/MS 
spectra was applied in Papers-I, III, and V.  
Peptide de novo sequencing. Peptide sequences could be infered directly from mass 
increments of fragment ions in MS/MS. As an alternative to a database search, peptide de novo 
sequencing is especially useful when the protein contents could not be referenced to a 
predefined database. For example, in Paper-IV, the sequence of human antibodies, especially 
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sequences from the complementary determining region (CDR), are of considerable 
uncertainty, due to the enormous possibility ( ~1015  in theory) of recombination and 
hypermutations (Schroeder and Cavacini, 2010). It is not feasible to provide a comprehensive 
reference database for matching all possible CDR sequences. In Paper-IV, pNovo+ (Chi et al., 
2013) was applied to produce reliable full-length peptide sequences directly from high-
resolution HCD/ETD spectral pairs (Savitski et al., 2005, Savitski et al., 2006a). In Paper-V, 
Novor (Ma, 2015) was used to generate de novo peptides from HCD spectra. In the absence of 
the complementary information from ETD, the latter approach (Paper-V) is arguably less 
accurate than the former one (Paper-IV). However, both methods applied stringent criteria for 
quality control, to achieve a reasonable accuracy of connecting the de novo sequences to their 
source proteins. The filtration was made by analysis of sequence similarity using protein 
BLAST (Altschul et al., 1990), with strict limits of sequence identity between de novo peptides 
and the protein sequences in the databases. 
Peptide identity propagation (PIP). To counteract the stochasticity caused by DDA and 
increase the reproducibility of peptide identification, PIP was applied in Paper-III, IV, and V. 
This option is implemented in MaxQuant as a feature of “match-between-runs”, and also in 
OpenMS (Kohlbacher et al., 2007, Weisser et al., 2013) as FeatureLinkerUnlabeledQT. PIP 
relies on reproducible LC chromatogram, calibrated retention time, as well as accurate 
measurements of the precursors’ m/z. Sequence identities of the chromatographic features 
were propagated across multiple LC-MS/MS experiments by the concept similar to the 
accurate-mass-and-time (AMT) tag (Smith et al., 2002) and the peptide mass fingerprint (PMF) 
(Moruz et al., 2013). An alternative to aligning chromatographic features that are detected by 
clustering isotopic peaks, the more sensitive (but less accurate) PIP could be done based on 
XIC, which is implemented by Skyline (Schilling et al., 2012) and OpenMS (EICExtractor). In 
Paper-III, both feature-based and XIC-based PIP approaches were combined, and quantitative 
estimations of FDR were applied.   
Protein inference. After associating MS/MS spectra with peptide sequences, protein 
inference was done by applying the principle of parsimony (Ma et al., 2009), which reports 
the minimum number of proteins covering the entire list of identified peptide sequences. The 
uniqueness of peptide-protein association was determined by whether a peptide could be 
attributed to more than one proteins. However, a protein group may contain more than one 
protein sequence (for example, isoforms) that share the same set of unique peptides. When 
the number of unique peptides is relatively small (often less than three), or the similarities 
between multiple protein sequences are relatively high (e.g., multiple isoforms per gene), the 
reported protein groups may contain multiple entries of the database.   
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Figure 2.2 | Segmented DDA and peptide identity propagation. In Paper-V, the full-
range survey MS spectra were applied in each experiment and were assembled into 
chromatographic feature maps. However, MS/MS was applied to analyze precursors 
in three different m/z ranges (low, mid, and high). MS/MS-derived identifications 
results were assigned to the feature maps and propagated between experiments. A 
consensus feature map was generated by aligning and combining all the individual 
feature maps.  
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The choice of a protein database affects not only the search space for peptide 
identification but also the complexity of protein inference when applying the parsimony 
principle. In Paper-I, the UniProt “Human Complete Proteome” (composed of canonical and 
additional sequences) was used. In Paper-II the Ensembl database derived from the 
Saccharomyces cerevisiae (Yeast) genome was used. In Paper-III, the UniProt (SwissProt) 
database of yeast proteins was provided in the data of iPRG-2015-study. In Paper-IV, the 
UniProt (SwissProt) database of human proteins was used for the first-pass MS/MS 
identification for excluding known sequences, and also used for the BLAST search for 
sequence similarities with de novo peptides. In the final step, the SwissProt database was 
concatenated with the de novo peptide sequences for implementing traditional MS/MS 
identification. In Paper-V, as the 20 mixture contains three proteome components (human, 
yeast, and BSA), a concatenated UniProt “reference proteome” database was generated to 
cover the proteins that are likely to be observed in the samples. Common contaminants such 
as BSA, trypsin, and various keratins (from hair and skin) may hinder the identification 
process if the corresponding sequences are not included in the database. For this reason, an 
additional database that contains such proteins sequences was searched together with the 
main database, but peptides linked to potential contaminations were excluded from 
subsequent analysis.  
 
 
Quantification 
 
Label-free quantification (LFQ) is the primary method that has been investigated in this 
thesis and has been performed at different levels. In Paper-I, quantification was only carried 
out at the level of chromatographic features, for illustrating the abundance distribution of the 
newly identified co-fragmenting precursors. In Papers II, III, and partially in Paper-IV, the 
quantification was done at the peptide-level by summing up abundances of features 
attributed to the same peptide sequences. In Paper-V (and partially in Paper-IV), the 
quantification was investigated at the protein-level. Four traditional protein summarizing 
approaches (MaxLFQ, PQPQ, Top-3, and Median) were compared with the newly proposed 
Diffacto method. MaxLFQ summarizes relative protein abundances by linear regressions 
based on pairwise peptide log-ratios (Cox et al., 2014); PQPQ clusters peptides by measuring 
the linear correlations of log-abundances among multiple runs (Forshed et al., 2011, Zhu et al., 
2014), the abundance of the largest cluster of peptides was summed up; Top-3 sums up the 
 Ph.D. Thesis Chapter two: Present Investigations 
- 33 - 
 
abundances of the most intensive three peptides (Silva et al., 2006); the Median approach uses 
the mid-points of all peptide abundances. In the Diffacto approach, relative protein 
abundances were summarized by weighted geometric means of peptides’ log-ratios. Unlike 
the compared methods that generate per-experiment protein summarization, the abundances 
of proteins were given by sample groups in the Diffacto results.  
Missing values are obstacles in protein quantification, especially, LFQ. In Paper-III, the 
problem of missing values for peptide quantification has been investigated. By performing 
peptide identity propagation (PIP), the identities of the chromatographic features were 
inferred, and the quantitative information was directly extracted from the features. However, 
feature-based PIP only alleviated but did not fully solve the missing value problem. The more 
sensitive XIC-based PIP was applied to further recover the remaining missing values. Quality 
control is important in this process. A target-decoy approach was the applied for estimating 
the reliability of XIC. For each precursor ion, two target peaks (monoisotopic and the first 13C 
isotopic, i.e., M and M+1) and two decoy peaks (by shifting precursor’s m/z and RT) were 
extracted from the MS1 spectra, and were scored based on the mass and RT deviations, as well 
as the CV between replicate experiments. A score threshold corresponding to 5% FDR was 
applied to assess the quality of XIC. This quality threshold was also applied in Paper-V.  
Nevertheless, for the protein-level summarization in Paper-V, the missing value 
problem was further addressed by the proposed Diffacto algorithm. In the calculation of 
weighted geometric means, only the valid (non-missing) measurements were used. If only a 
significantly large proportion of peptide quantities went missing (for a specific sample group), 
the remaining missing values were imputed as bellow the detection limit.  
Factor analysis was applied in Paper-V to measure the covariation of peptide 
abundances from multiple measurements by LC-MS/MS. A Bayesian factor analysis 
algorithm, FARMS (Hochreiter et al., 2006) that was originally developed for summarizing 
gene expression microarray data, was adapted for handling proteomics datasets. Similar to 
the PQPQ approach that measures the correlation of peptide abundances, factor analysis 
estimates the consistency of peptide signals by comparing to the estimated underlying factor 
reflecting the concentration changes of the protein. Peptides with incoherent trends of 
quantities were deemed as unreliable and were down-weighted or excluded from the protein 
summarization. The factor analysis was an unsupervised process, which estimated for each 
protein the proportion of information content (S/N) (Talloen et al., 2007) in the quantitative 
measurements of peptides, without using the information about the identities of samples. 
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False quantification rate (FQR) was investigated in Paper-V. For each protein 
quantified from the 20-mixture data, the ranks of 190 pairwise ratios were correlated, between 
the reference concentrations and the quantification results, using Spearman’s rank correlation. 
Proteins with negative correlation (below the threshold r = 0) were considered as false 
quantifications. 
 
 
Statistics 
 
Peptide and protein identification was filtered at less than 1% FDR by the target-decoy 
approach (Elias and Gygi, 2007), with the assumption that MS/MS spectra could match to 
artificial sequences by chance, which reflect the proportion of random matches to the target 
sequences at a given threshold. In Paper-III and Paper-V, the peptide identity propagation 
(PIP) were controlled at FDR < 5%, using a similar target-decoy approach where the decoy 
features were created by shifting the m/z and RT values of target features.  
For quantification of differentially expressed proteins in comparative analysis, the 
statistical significance was given by FDR < 5%. In Paper-IV, FDR estimated by Bonferroni 
correction of p-values derived from pairwise t-tests. In Paper-V, FDR was calculated as q-
values derived from p-values of either AVONA or Monte Carlo random permutation tests 
(Sandve et al., 2011), with a conservative estimation of the proportion of true null hypotheses 
(Pounds and Cheng, 2006).  
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2.2 Results and Discussions 
 
 
Natural multiplexing of MS/MS data 
 
In Paper-I, we investigated the identification efficiency of high-resolution MS/MS spectra 
from a set of single-dimensional shotgun proteomics experiments. We found that DDA-
derived MS/MS data frequently contain chimeric spectra, which is against the paradigm of 
“one MS/MS spectrum – one peptide identification” in traditional database search 
algorithms. Naturally, chimeric spectra contain the information about other precursors that 
were not initially targeted by DDA but were co-eluted from the LC and co-fragmented in the 
MS/MS. We observed a correlation between the width of precursor isolation window in DDA 
and the rate of acquiring chimeric MS/MS spectra, as well as the negative impact of chimeric 
spectra on the peptide identification. Estimated by the proportion of MS/MS spectra that 
contain both lysine (m/z 147.11280) and arginine (m/z 175.11895) peaks as the C-terminal (y1+) 
ions, we found that a majority of over 98% MS/MS spectra were chimeric.  
By associating precursors’ chromatographic features with the isolation windows of 
MS/MS data acquisition, we generated clonal MS/MS spectra with the same fragment mass 
peaks but newly assigned precursor information. We matched these spectra via database 
search, using a simplified scoring method that did not penalize the existence of unrelated 
peaks. As a result, we obtained significantly more PSMs and peptide identifications at the 1% 
FDR level.  
We demonstrated the power of natural multiplexing from traditional DDA-derived 
MS/MS data, by applying MS/MS spectral cloning that broke down the old paradigm and 
yielded more than one peptide ID per MS/MS spectrum (Figure 2.3). An integrated data 
analysis workflow, DeMix, was developed on top of the OpenMS pipelines. DeMix 
transformed the previously unwanted events, i.e., co-fragmentation of peptides, into an 
advantage of multiplexing. We achieved an overall identification rate of 1.25 PSM per MS/MS 
spectrum, which exceeded the instrumental limit of data acquisition rate and yielded nine 
peptides per second identification efficiency.  
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Figure 2.3 | Multiplexing MS/MS (an example).  The spectrum was associated with 
four peptide precursors and was identified from the DeMix workflow. 
[HGDGTTLDIMLK]2+, m/z 650.8311; [ALVGGAVGGLAGAASK]2+, m/z 649.8724; 
[FVAFSGEGQSLR]2+, m/z 649.3308; and the original precursor, [QMCICADFEK]2+, 
m/z 651.2697.  
 
 
We showed that the identified co-fragmenting peptides mainly came from the middle 
or low abundance range (Figure 2.4), which increased the dynamic range of data analysis and 
improved the reproducibility of peptide identification between experiments.  
In principle, widening the precursor isolation window will associate more 
chromatographic features to the MS/MS spectra, increasing the capability of multiplexing. 
However, we observed a decreasing trend of identification efficacy for spectra acquired from 
isolation windows that are wider than 4.0 m/z. Possible explanations might be that the 
chimeric spectra become too noisy, or the ions of the dominate fragments suppress the signals 
of other ions and decrease the overall S/N of the spectra. This observation may raise a concern 
about the effectiveness of analyzing lower abundant peptides via DIA approaches that use 
much wider (>20 m/z) isolation windows, although the burden of identification is different 
between DDA and DIA data.  
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Figure 2.4| Abundance distributions of chromatographic features. Gray: all peptide-
like features detected in LC-MS; blue: identified peptides targeted in conventional DDA 
strategy; yellow: peptides additionally identified by feature-based deconvolution. 
 
 
Quantification-centered proteomics 
 
It is frequently claimed that DDA has a stochastic tendency that causes the problem with 
missing values in quantification. However, since DDA is a strategy for acquiring MS/MS data 
and serves the purpose of identification, the survey spectra (MS1) that are acquired before 
MS/MS should remain unbiased to all precursors. Therefore, the trouble with DDA-induced 
missing values should not be a fundamental problem for the quantification process that is 
performed at the level of MS1.  
One of the key findings in Paper-I was that the chromatographic features assembled 
from MS1 spectra could provide reliable information about not only the accurate mass of 
precursors but also their quantities (i.e., intensities). In light of the DeMix workflow, we 
looked for a novel strategy that focuses on the quantitative aspect of proteomics data. Thus, 
in Paper-III, we developed an extension to the workflow, named DeMix-Q, that does the job 
of quantification while avoiding some pitfalls in the identification processes.  
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We demonstrated, in Paper-III, that peptides’ identities that are inferred from MS/MS 
could be reliably propagated across multiple LC-MS/MS experiments, by aligning individual 
maps of chromatographic features that create a consensus feature map (see Figure 2.2). 
Although such strategy was already implemented in both MaxQuant and OpenMS, the 
performance was not satisfactory. We still observed significant proportions (ca. 15%) of 
missing values in the quantification outputs, when analyzing the data of iPRG-2015 study that 
repetitively measured, technically, the same proteomic contents. On the contrary, missing 
values composed only less than 2% of the quantitative data (derived from the Skyline 
workflow) provided by the iPRG-2015 study. However, we found, in the Skyline data, the CV 
of the quantities between replicated experiments was significantly larger than that of the 
MaxQuant and OpenMS results. The reason was, Skyline extracted XICs without quality 
control; while MaxQuant and OpenMS, on the other hand, generated chromatographic 
features that are “peptide-like”, based on the isotopic distributions of precursor peaks and the 
shapes of peptides’ eluting profiles.  
 
 
 
 
Figure 2.5 | Comparison of five quantification approaches regarding missing values.  
The fraction of peptides quantified in all runs drops as a function of sample size but 
with different rates for different quantification methods. 
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In the DeMix-Q workflow, we integrated the reliable feature-based PIP with the 
sensitive XIC-based PIP, and also applied FDR estimation in the latter approach for quality 
control. In addition, DeMix-Q implemented a global normalization of abundances, which 
corrects for each LC-MS/MS experiment the time-dependent median abundance shifts of 
features by comparing to the global medians. After normalization, the systematic errors 
caused by the fluctuation of peptide ionization were removed from the peptide quantities. As 
a result, DeMix-Q achieved sensitive and reproducible peptide quantification with less than 
3% missing values when measuring 26,753 peptides in the 12 replicated LC-MS/MS 
experiments. Remarkably, the median CV of peptide quantification in 12 replicated runs 
decreased from 22.7% (Skyline) to 11.6% (DeMix-Q). 
 
 
 
Figure 2.6 | Comparison of CV distributions. DeMix-Q provided lower median CV 
than other methods while quantifying the largest number of peptides across all runs. 
Median CVs: DeMix-Q: 11.6%, OpenMS: 18.6%, MaxQuant: 21.9%, Skyline: 22.7%. 
 
 
As demonstrated in Paper-I and Paper-III, chromatographic features generated from 
MS1 spectra are, in fact, reproducible and quantitative measurements of peptides ions. 
MS/MS-derived identifications were later associated with these quantitative measurements. 
Therefore, the relation between the identification and quantification may be well reversed. 
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The peptide identification result may likely compose a subset, rather than a superset, of the 
quantified chromatographic features.  
We showed that more than a hundred thousand of peptide-like features could be 
detected in single LC-MS/MS experiment, even for a less complexed (yeast) proteome. 
Typical DDA data could merely identify one-third of these features and are biased against the 
lower abundant species. In that sense, with an ever-increasing size of proteomics studies, 
DDA-derived MS/MS spectra become more and more redundant, especially, for the 
abundant peptides and proteins. Thus, we made a hypothesis: repetitively identifying the 
most abundant peptides by MS/MS is unnecessary, then demonstrated that reproducible 
quantification could be achieved in the absence of redundant MS/MS data. With all the 
findings in Paper-I and Paper-III, we proposed the quantification-centered strategy for 
proteome-wide data analysis.  
In Paper-V, we generated a set of LFQ data that consists of 63 experiments to measure 
the mixtures of three proteome components in 20 different concentrations. The DDA strategy 
applied for this dataset was intentionally segmented to three mass ranges in the triplicated 
measurements (see Figure 2.2). Consequently, for each of the experiment, around two-thirds 
of the peptide identifications had to be propagated from other experiments by aligning the 
chromatographic feature maps. Nonetheless, the segmented DDA did not prevent us from 
obtaining reproducible quantification results. The fraction of missing values in peptide 
quantification was only 12%, which was mainly due to the limit of detection. The median CV 
of replicated measurements was 12%, which was in line with our previous findings of LFQ.  
When summarizing peptides’ quantities to the abundances of proteins, the difficulty is 
often underestimated in traditional identification-based approaches. However, the concept 
for the quantitative analysis is similar between shotgun proteomics and the old-style gene 
expression microarrays. With the increased proteome coverage and the improved 
reproducibility of LC-MS/MS experiments, the data structures between MS-based shotgun 
proteomics and microarray-based transcriptomics become more and more similar. Therefore, 
we brought a widely-used summarizing method from transcriptomics to proteomics, which 
applies a Bayesian factor analysis algorithm to measure the covariation of peptides’ signals in 
response to protein concentration changes. The factor analysis enabled the quality assessment 
for quantitative analysis. By this approach, peptides with incoherent trends of abundance 
changes could be detected from the covariation metrics, and the overall signal-to-noise ratio 
(S/N) could be estimated for each group of peptides that are tentatively attributed to the same 
source protein. Factor loadings, reflecting the correlation between the peptide abundances 
underlying factor of the concentration change, provided weights of individual peptides and 
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removal of unreliable quantities; S/N values indicated the overall consistency of peptides’ 
abundances and were used to categorize the protein quantification results as informative or 
non-informative. The distribution of S/N exhibited a strong correlation with the number 
constituent peptides, showing the vital importance of having multiple quantitative 
measurements per each protein (Figure 1 in Paper-V).  
With the two-level quality controls based on the factor analysis, we demonstrated the 
improved quantification accuracy with reduced errors in summarizing the LFQ dataset. 
Compared to the traditional approaches, the false quantification rate dropped from as much 
as 14% to 1.6% (Figure 2.7). In addition, the weighted summarizing approach addressed the 
problem with missing values that further improved quantification accuracy.  
 
 
 
Figure 2.7 | Evaluation of the precision of protein quantification results. Dashed 
lines: quantification based on MaxQuant (M) peptide abundances. Solid lines: 
quantification based on DeMix-Q (D) peptide abundances. Abundances of informative 
proteins summarized by different techniques were correlated to the actual protein 
concentrations. The proportions of quantified proteins (y-axis) at the correlation 
threshold (r = 0) were used to estimate false quantify cation rates: 14.3%, 9.6%, 4.3%, 
1.6%, 0.68%, and 0.13%, respectively in Top3 (D), Median (D), PQPQ (D), Diffacto (D), 
MaxLFQ (M), and Diffacto (M) results.  
 
 
We named the summarizing method Diffacto, for relative quantification of differentially 
expressed proteins based on factor analysis. We applied Diffacto to analyze two sets of data 
generated from clinical breast cancer studies and revealed the persistent proteomic signatures 
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of three subtypes of breast cancer. We improved the consistency of the quantification results 
between the two independent studies.  
In addition to the flexible quantification approach, a reliable FDR estimation method 
was also applied, based on sequential Monte Carlo random permutation tests (Sandve et al., 
2011). Such non-parametric statistical approach provided conservative FDR control for 
proteomics studies with complex designs.  
 
 
 
Figure 2.8 | Expression patterns of the differential proteins. Protein fold-changes 
estimated by Diffacto (weighted geometric means) showed good agreements not only 
in the directions of regulation, but also in the magnitudes of changes between the results 
from CPTAC and MIPB data. Such protein expression patterns clearly clustered into 
three groups that represent the most persistent proteomic signatures of the three 
subtypes of breast cancer. 
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Discovering biomarkers in the hidden proteome 
 
In Paper-II, we developed a novel MJ-cIEF device (named pI-Trap) for sample fractionation. 
By establishing a stable pH gradient and an electric field, the device focuses protein or peptide 
molecules in different regions of the capillary column, according to the pI properties. Sample 
fractionation was done by sequentially collecting the samples flowed through the cIEF column 
(see Figure 2.1 and Figure 1 of Paper-II). 
To calibrate the pI gradient of the sample fractionator, we associated the center locations 
of the eluting profiles of peptides with theoretical pI values. The tight regression curve 
indicated the high precision of the pI estimation. By instrumental optimizations, we decreased 
the standard deviation of the pI prediction from 0.44 to 0.21 for the whole range of peptides. 
The MJ-cIEF device was initially designed for providing an orthogonal dimension of 
sample fractionation prior to LC and MS. With the pI fractionation one can decrease the 
dynamic range in complex proteomes, such as the human blood proteome (dynamic range 
larger than 10 orders of magnitude). In addition, the searching space in the identification 
process could be limited by the pI ranges, which could increase the specificity of PSMs. 
Compared to the gel-based HiRIEF approach that is limited to a narrow (e.g., acidic) range of 
peptides (Branca et al., 2014), our method covered a much wider range of peptides including 
neutral and basic ones, although did not show a comparable resolution.  
As discussed in the paper, our approach can be used to analyze PTMs that modify the 
chargeable groups of proteins. The PTMs that introduce pI changes could be due to protein 
damage. Accordingly, the changes of pI will shift the focusing positions of these molecules, 
moving them out of the shadow of other proteins that have extreme abundances (e.g., serum 
albumins). Therefore, pI shifting PTMs could be used as potential biomarkers of diseases 
related to protein damages, such as the Alzheimer’s disease.  
In Paper-IV, we tried another approach to decrease the dynamic range in the blood 
proteome by enriching polyclonal antibodies (i.e., IgGs). However, sequences of native 
human antibodies are of vast heterogeneity, due to the recombination, hypermutation, and 
PTMs. Consequently, it is practically not feasible to create a comprehensive reference database 
for identification of antibody-derived sequences. Therefore, we made an attempt to analyze 
blood antibodies using peptide de novo sequencing, which did not depend on the a priori 
knowledge about the protein sequences.  
We found that de novo sequences revealed a hidden proteome that has almost the same 
size and similar properties (e.g., abundances) of the typical and searchable proteome. The 
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expansion of IgG-derived sequences rendered a subdomain of “IgGome” in the blood 
proteome. Utilizing the hidden proteome, we gained a high predictive power of 
differentiating blood samples from the patients with Alzheimer’s disease and the patients 
with Dementia with Lewy Bodies.  
In Paper-V, we demonstrated another implementation of de novo sequencing. We made 
a Diffacto analysis based on the iPRG-2015 data, where the chromatographic features were 
associated with de novo peptides and were subsequently attributed to the abstract sources of 
proteins by BLAST search against the universal SwissProt database. Even with such an 
identification procedure, we still obtained the high specificity in detecting all the spike-in 
proteins, as well as the accurate estimation of the relative protein abundances. Our results 
showed the usefulness of the quantification-centered data analysis, which provided a 
“spotlight” for conducting proteomics studies in the absence of “reference” databases. 
 
 
 
 
Open source projects 
 
Source codes and pipelines of the workflows developed for this thesis are freely available via 
GitHub.com.  
 
DeMix: a workflow for identification of co-fragmenting peptides. 
https://github.com/userbz/DeMix 
DeMix-Q: a quantification-centered data analysis workflow. 
https://github.com/userbz/DeMix-Q 
Diffacto: finding differentially expressed protein by factor analysis. 
https://github.com/statisticalbiotechnology/diffacto 
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CHAPTER THREE: CONCLUDING REMARKS 
 
 
 
In this thesis, I present the analytical methods developed during the four years of my Ph.D. 
study. The DeMix workflow started from improving the identification aspect of shotgun 
proteomics data analysis, which changes the paradigm of processing MS/MS data and uses 
the rich information from chimeric spectra to identify more than one peptide per spectrum. 
The expansion of peptide and protein identification from the co-fragmenting peptides 
increased the proteome coverage and dynamic range of data analysis.  
In light of the successful implementation of DeMix, the quantitative extension of the 
workflow (DeMix-Q) addressed the reproducibility problem in label-free quantification. A 
new procedure for peptide identity propagation (PIP) has been introduced to rescue the 
missing peptide measurements. Based on the results of DeMix-Q, the idea of quantification-
centered proteomics has been proposed for processing high-resolution shotgun proteomics 
data in large-scale. 
In the practice of the quantification-centered proteomics, the Diffacto approach for 
proteome summarization was presented. By applying factor analysis, Diffacto seeks to 
differentiate between signals and noises from the covariation of peptides’ abundances 
measured in multiple experiments. The covariation structure accurately reflects the protein 
concentration differences, which also provides the basis for a reliable quality control for 
quantifying differentially expressed proteins between biological conditions. Therefore, the 
false quantification rate has been reduced. In addition, with the released burden of 
identification, peptide de novo sequencing has been implemented to characterize complex 
proteomes, which is highly flexible in terms of protein identification and is no longer strictly 
limited to the reference sequence database. 
In my opinion, the rapid development of high-resolution mass spectrometry will 
continue, and mass spectrometers will become faster, more sensitive, accurate, and cost-
effective (Eliuk and Makarov, 2015). Accordingly, the scale of quantitative proteomics studies 
will increase significantly, providing the basis for quantification-centered proteomics. MS-
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based shotgun proteomics will soon become a data-intensive research field, where more 
advanced bioinformatics methods can be implemented.  
One the problem that has frequently been mentioned is the reproducibility issue caused 
by DDA. However, since the problem can be well-addressed by the proposed methods in this 
thesis, the boundary between DDA and DIA for MS/MS data acquisition might likely blur. It 
is possible to implement both DDA with DIA within the same experiment, and subsequently 
analyze the data using a universal processing workflow (Tsou et al., 2015). The Diffacto 
approach for proteome-wise summarization is, in principle, applicable to data of DIA data 
and targeted proteomics, which could be an interesting extension to the current study. 
High-resolution MS offers unprecedented specificity for associating complex mass 
spectra with the identities of the analytes and simplifies the identification process. Also, the 
combination of complementary fragmentation techniques has become practical, such as 
EThcD that combines ETD with HCD within one fragmentation process (Frese et al., 2012). 
Such techniques may double the information contents in each MS/MS spectrum, and further 
increase the specificity of peptide-spectral matching. Using the complementary information 
in new algorithms may improve the accuracy of both peptide database search and de novo 
sequencing. 
As shotgun proteomics studies expand in depth and sizes, the quantitative data 
structure resembles that of microarray-based transcriptomics. Therefore, many problems we 
encountered in proteomics, such as the demonstrated summarization problem, might already 
have practical solutions in transcriptomics. Compared to microarrays, modern mass 
spectrometers provide higher dynamic range and better quantitative accuracy, which should 
make transcriptomics-oriented algorithms easy to be implemented in shotgun proteomics.  
While proteomics is becoming a data-driven research field, techniques of data science 
(e.g., machine learning) can be applied to extend our understandings of the complex 
properties and elusive mechanisms in proteomics, such as retention time, isoelectric point, 
enzymic cleavage, isotopic distribution, ionization efficiency, charge distribution, and gas-
phase reactions. Integrating high-dimensional information into the analytical procedures will 
enhance the utility of proteomics data.  
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